Development of the mouse embryo to the blastocyst stage occurs over 3 to 4 days following fertilization of the oocyte. During this time, several molecular and morphological events take place that result in the formation of three distinct cell lineages: the trophectoderm, the epiblast, and the primitive endoderm. Many studies have investigated the processes that control lineage specification in the blastocyst including gene expression, cell signaling, cell-cell contact/positional relationships, and most recently, epigenetics. Here we review, at the molecular level, recent contributions to our understanding of the mechanisms that play a role in formation of these lineages. Additionally, we focus on the next steps in differentiation to highlight processes important in the development of those lineages that contribute to the extraembryonic tissues. In this context, we discuss the establishment of extraembryonic ectoderm and the contributions of parietal and visceral endoderm to yolk sac formation.
INTRODUCTION
After fertilization of the oocyte, during the first few days of mammalian development, several significant morphological and molecular events occur that result in the formation of the blastocyst. In conjunction with cleavage divisions of the blastomeres, these events begin with and include the maternalto-zygotic transition, in which the control of development is passed from maternal gene products accumulated in the oocyte to gene products actively transcribed from the genome of the newly formed embryo. Following this event, at the 8-cell stage, the embryo undergoes the process of compaction, marking a morphological change in the blastomeres of the embryo, in which they become smooth and flattened, and the distinction between intercellular boundaries becomes less marked. These changes are associated with an increase in cell-to-cell adhesion facilitated by the formation of intercellular junctions. At the 32-cell stage, around Embryonic Day 3.5 (E3.5), the fluid-filled blastocoelic cavity begins to form, giving rise to the blastocyst. Before the mature blastocyst forms, by E4.5, two lineage segregation events have taken place. The first segregation event is the differentiation of trophectoderm (TE) and specification of the pluripotent inner cell mass (ICM) at around E3.5. The second segregation event is the differentiation of a subset of ICM cells into primitive endoderm (PE), which leaves the remaining ICM cells to make up the pluripotent epiblast (EPI). ICM cells are sometimes referred to as bipotent, as they can give rise to both PE and EPI. Conversely, EPI cells have recently been referred to as the ''true ground state,'' as they can give rise to all embryonic lineages, except for PE and TE [1] . At E4.5, a fully developed, mature blastocyst is ready to implant. The important events accompanying pre-and periimplantation development, such as blastomere polarity, embryonic asymmetry, and axis patterning, have been well studied and are presented and reviewed in detail elsewhere [2] [3] [4] [5] [6] [7] .
In the following article, using the mouse as a model, we will discuss molecular pathways, including transcription factors, signaling events, and epigenetic modifications, that are important in the initial specifications of the TE and the ICM, as well as of the PE and the EPI. We will then focus on the subsequent development of extraembryonic tissues from these cell lineages, including the extraembryonic ectoderm (ExE), and the contributions of parietal endoderm (PaE) and visceral endoderm (VE) to yolk sac formation.
LINEAGE DETERMINATION PART 1-TE VERSUS ICM
The first cell type to differentiate during mammalian development is the TE. Comprising the outer layer of the blastocyst, the TE displays characteristics of a transporting epithelium, including apical-basal cell polarity, intercellular junctions, and transport of ions across the TE, which facilitates and is necessary for formation of the blastocoele cavity [3] [4] [5] 8] . At the anatomical level, TE differentiation begins with asymmetric cellular divisions that occur at the 8-to 16-cell transition and effectively allocate cells either to the outside surface (outer) or inner layer of the embryo (Fig. 1) . At the 16-to 32-cell transition, subsequent cellular divisions of the outer layer then occur either symmetrically, generating two daughter cells that remain on the outside, or asymmetrically, resulting in one outer and one inner daughter cell. These blastomeres that make up the outer layer of the embryo differentiate to form the TE, while the inner cells become the ICM, both of which are lineage specifications that require the interaction of specific transcription factors [3] [4] [5] . The question of whether TE cell fate is determined by its position within the embryo (''insideoutside hypothesis'' [9] ) or by inheritance of different cellular components as a result of asymmetric divisions of cells that are polarized along the apicobasal axis at the 8-cell stage [10] is thoroughly discussed and reviewed elsewhere [4, 5] .
At the cellular level, the expression of specific transcription factors and, in particular, that of the caudal type homeobox CDX2 is essential for proper TE differentiation [11, 12] . It was initially believed that Cdx2 expression from the zygotic genome was required for TE differentiation beginning at the 8-cell stage, when Cdx2 expression is detectable in all blastomeres and becomes restricted to the outer cells as blastocyst formation proceeds [12] . However recently, Jedrusik et al. [13] have shown that a maternally derived Cdx2 pool, which is present in the zygote prior to genome activation, is also required for TE specification and differentiation. In experiments in which both the maternal and the zygotic Cdx2 pools were depleted in embryos, beginning immediately after fertilization, developmental arrest resulted at earlier stages than would be expected based on depletion of zygotic Cdx2 alone [13] . Developmental arrest in these embryos was also associated with defects in expression and localization of molecules such as PAR3 and aPKC, markers of cell polarity, as well as failure of compaction at the 8-to 16-cell stage. A previous study by Jedrusik et al. [14] showed that interaction between CDX2 and aPKC reinforces blastomere polarity, as CDX2 expression leads to upregulation of aPKC. At the same time, those authors found that blastomere polarity influences CDX2 expression through asymmetric distribution of Cdx2 mRNA. As a result, divisions generating inside and outside cells are also asymmetric with respect to the Cdx2 distribution, and therefore, outside cells receive the instructions to differentiate to the trophoblast fate [14] .
Although CDX2 is essential for TE differentiation, other transcription factors have also been shown to be important, such as the EOMES T-box gene [11] . The Cdx2 gene has been shown to be upstream of the Eomes gene and, while either a zygotic Cdx2 or Eomes mutation results in failure of normal blastocyst development and implantation, initial events of TE differentiation and blastocyst formation, including cell polarization, compaction, and blastocoele formation, are initiated in the absence of zygotic expression of these genes [11, 12] . However, it is likely that the presence of the maternal CDX2 protein is enough to initiate the blastomere polarization process. Thus, these results support the findings by Jedrusik et al. [13, 14] but also suggest that there are likely other factors upstream of zygotic Cdx2 and Eomes activation. This is the case with TEAD4, a member of the TEA domain/transcription enhancer factor family that has been shown to be upstream and is required for both zygotic Cdx2 expression and TE differentiation [15] [16] [17] . In 2009, building upon their previous study, Nishioka et al. [15] showed that TEAD4, in coordination with its coactivator protein, Yes-associated protein 1 (YAP1), could induce Cdx2 activation and that of other trophoblast genes in embryonic stem (ES) cells and control Cdx2 622 expression and TE fate in embryos. Furthermore, those authors went on to show that TEAD4-induced Cdx2 expression is dependent on phosphorylation status and nuclear localization of YAP1, in which phosphorylated, cytoplasmic YAP1 in inside cells prevents TEAD4-mediated Cdx2 expression. Conversely, nonphosphorylated nuclear YAP1 in outside cells is able to interact with and facilitate TEAD4-mediated Cdx2 expression. Those authors proposed that phosphorylation of YAP1 by the kinase LATS, in turn, may be controlled by cell contact and therefore LATS-mediated inhibition of YAP1 through the HIPPO signaling pathway [16, 18] . This hypothesis presents a model whereby positional information and cell-to-cell contact controls transcription factor-mediated TE determination. Most recently, a study by Ralston et al. [19] has shown that TEAD4 also regulates the expression of the zinc-finger transcription factor Gata3 gene in parallel with Cdx2 expression in the developing embryo [19] . While Gata3 expression is restricted to the TE and although short interfering RNA (siRNA)-mediated knockdown results in a delay in blastocyst development [20] , this factor does not appear to be essential for TE specification but rather acts together with CDX2 to induce the expression of genes important for the trophoblast lineage [19] [20] [21] . Taken together, these studies support the hypothesis proposed by Jedrusik et al. that both maternal and zygotic Cdx2 expression, as well as positional information, contribute to TE specification, and they also highlight the involvement of other genes in relaying these cues.
Just as a unique set of genes is important for TE specification, another unique set of genes is essential for maintaining the pluripotency of ICM cells. At the core of this group are the Pou5f1 [22] , Nanog [23, 24] , Sox2 [22, 25] , and Sall4 [26] genes. The Pou5f1 gene is essential for ICM fate determination [27] [28] [29] and, along with Sox2, also functions to suppress differentiation to TE [22, 25, 30] . The Nanog gene, a homeodomain transcription factor, has been shown to be important for ICM pluripotency and ES cell self-renewal [23, 24] , while the mammalian Spalt transcription factor Sall4 gene is required for development of the EPI and PE from ICM cells [26] . In contrast to the genes involved in TE specification, the Pou5f1, Nanog, Sox2, and Sall4 genes do not become restricted to the cells of the ICM until after blastocyst formation [31] . The interactions of these factors and the mechanisms controlling their expression are explored further, below.
EPIGENETIC CONTEXT OF BLASTOCYST LINEAGES SPECIFICATION
Epigenetic regulation acts through two types of chromatin modification. The first type acts through the modification of histones. Trimethylated residues Lys9 and Lys27 of histone H3 (H3K9me3 and H3K27me3, respectively) are the most wellknown histone marks of a repressive chromatin state, while acylated histones H3K4me3 and H3K9 (H3K9ac) are the most well-known markers of an active chromatin state. These modifications are heritable through mitosis, although they can be easily removed, and therefore, this type of repression/ activation is relatively dynamic [32] . The second type of chromatin modification consists of DNA methylation of cytosine residues in CpG dinucleotides, which results in gene silencing. This modification is heritable through mitosis, and there are only two known cases in development when DNA methylation can be removed: after fertilization and in primordial germ cells. In the majority of cell lineages, DNA methylation irreversibly locks in the transcriptionally inactive state [32, 33] .
Keeping ICM and EPI Pluripotent
In order to sustain the pluripotency of ICM and EPI, two epigenetic regulations are required: the chromatin of pluripotency-related genes must be kept active, and simultaneously, the chromatin of differentiation-promoting genes must be kept repressed.
Shortly after fertilization, the majority of DNA methylation marks become erased, resulting in global genome demethylation, which reaches a maximum at the morula stage (Fig. 1A) . Thanks to this event, the pluripotency-sustaining Nanog and Pou5f1 genes become demethylated, and the genes are transcribed [32, 34] . Furthermore, pluripotency is sustained in ICM/EPI by the interplay among members of the pluripotency-related transcription factor quartet, POU5F1, NANOG, SALL4, and SOX2, and the epigenetic modifiers. Epigenetic modifiers activate pluripotency-related genes. In particular, CARM1, a specific methyltransferase of histone H3 arginine, facilitates Nanog and Sox2 upregulation [35] , while the demethylase, KDM4C (JMJD2C), reverses the H3K9me3 repressive mark at the Nanog promoter and hence keeps this gene active [36] . Pluripotency-related transcription factors, in turn, activate epigenetic modifiers; for example, POU5F1 positively regulates the Kdm3a and Kdm4c genes [36] , and POU5F1, NANOG, and SOX2 were shown to bind the promoters of epigenetic repressors, such as the Eed, Suz12, and Ezh2 genes, and promoters of other epigenetic regulators, such as the Phc1, Ehmt2, Ehmt1, Dnmt3a, Dnmt3b, Hells, Kdm3a, and Kdm3b genes [37] . At the same time that epigenetic activation of pluripotency-related genes occurs, the epigenetic silencing of differentiation-related genes must take place to keep ES/ICM/EPI cells pluripotent. In ES cells, the chromatin of differentiation-related genes, including members of the Hox, Dlx, Irx, Lhx, Pou, Pax, and Six gene families, is occupied by the epigenetic repressors polycomb repressive complexes 1 and 2 (PRC1 and PRC2) and bears the H3K27me3 repressive marks [33] . In ICM and ES cells, the ERG-associated protein with SET domain (ESET), a histone H3K9 methyltransferase, epigenetically represses TE-specifier Cdx2 expression. The recruitment of ESET to Cdx2 is facilitated by POU5F1. Hence, the interaction of pluripotency-related transcription factor POU5F1 and epigenetic regulator ESET restricts differentiation of ICM into TE lineage [38, 39] .
Deciphering the detailed mechanism by which epigenetic regulators, interplaying with pluripotency-related transcription factors, sustain pluripotency of ICM and EPI will continue to be an exciting and important field of investigation.
Let Them Differentiate!
For differentiation to proceed, whether to TE at E3.5, to PE at E4.0, or to embryonic lineages after E4.5, pluripotency sustaining factors must be silenced. Studies of differentiating cultured embryonic cells, which mimic EPI at the implantation stage (i.e., around E4.5), have demonstrated that silencing of the Pou5f1 gene starts with the repressive action of transcription factors and is followed by repressive changes in histone marks mediated by the EHMT2-EHMT1 methyltransferase complex. This silencing is ultimately followed by DNA methylation of the Pou5f1 promoter region, which occurs by the EHMT2-recruited methyltransferases DNMT3A and DNMT3B to ensure blocking of Pou5f1 re-expression [40] [41] [42] . The other pluripotency-sustaining gene, Nanog, was also shown to be epigenetically regulated in pluripotent cells and epigenetically silenced during differentiation. In pluripotent cells, KDM4C demethylase reverses epigenetic inhibition of EARLY LINEAGE DETERMINATION IN THE MOUSE Nanog expression. In the absence of POU5F1, transcription of the KDM4C demethylase no longer occurs, which leads to epigenetic inhibition of Nanog expression [36, 43] . It was reported that upon differentiation into TE, Nanog DNA also becomes methylated and that the chromatin bears repressive marks mediated by the EHMT2-EHMT1 complex and the EZH2 methyltransferase [37, 44] .
Elf5, the Gatekeeper: Epigenetic Locking of the Trophoblast Lineage
At late morula/early blastocyst stage, cells still demonstrate some level of cell fate plasticity, and the expression of TE/EPI/ PE cell lineage markers is stochastic and may fluctuate [45, 46] . As previously mentioned, determination of the TE lineage is controlled by CDX2 and EOMES transcription factors. One direct target of CDX2 is the Elf5 gene, which appears at the later phase of the TE determination process. ELF5, a member of the ETS transcription factor family, creates a positive feedback loop with CDX2 and EOMES, which is necessary for enhancing their expression and canalizing the TE cell lineage fate [47] . In ICM/EPI cells, the Elf5 gene is methylated and hence becomes permanently silenced. Without ELF5, the EOMES-CDX2-ELF5 TE-promoting feedback loop is broken, levels of Cdx2 and Eomes expression fade away, and TE fate is aborted. In this way, methylation of the Elf5 gene functions as the epigenetic gatekeeper, blocking ICM cells and any of their derivatives from entering the TE fate path (Fig. 1A) [47] .
Paternal X Chromosome Stays Inactive in TE and TE Derivatives and Is Reactivated in ICM/EPI
One of the most noticeable differences between the epigenetic state of TE and that of ICM is the selective inactivation of the paternal X (Xp) chromosome in TE and its derivatives. At some point after fertilization, after the four-cell stage, Xp chromosome becomes inactivated in all cells of the early embryo, and this inactivation is heritable through mitosis. It remains inactivated in TE and its derivatives, while in the ICM and EPI, Xp undergoes reactivation. Starting from the period shortly after implantation, X chromosomes in EPI undergo random inactivation, so that in a given cell, either the maternal X (Xm) or Xp chromosome is inactivated (Fig. 1A ) [48, 49] . The mechanisms of Xp inactivation and random X chromosome inactivation are thoroughly reviewed elsewhere [32, 50] . In PE, as in TE, Xp chromosome is inactivated [51] . The mechanism of Xp inactivation in PE might be similar to that in TE. However, this problem has not been addressed directly. The reactivation of Xp in ICM/EPI allows for a short window of time in which both copies of the X chromosome are active. Pluripotency-sustaining factor NANOG possibly plays a role in the reactivation of Xp [52] . Moreover, removal of X chromosome methylation is considered to be a marker of a truly ground state of cell pluripotency acquired by EPI cells [1] . That raises the question of whether there is a need for the expression of some genes from both Xm and Xp chromosomes in EPI for proper development of the female organism or whether Xp reactivation is needed only for enabling further random X chromosome inactivation.
LINEAGE DETERMINATION PART 2-PE VERSUS EPI
The second differentiation event in preimplantation development is segregation of ICM cells into PE or EPI lineage, which is completed by E4.5, when both lineages are morphologically distinct and restricted to their respective fates. PE forms a monolayer of cells on the surface of ICM that directly faces the blastocoele and is separated from the more centrally located EPI by basal lamina. PE will give rise to the VE and PaE, while pluripotent EPI will give rise to the embryo proper and to the extraembryonic mesoderm [53] .
Molecular Mechanisms Leading to EPI Versus PE Segregation
Recent reports have demonstrated that the FGF/RAS/ MAPK signaling pathway plays a crucial role in the segregation of PE from EPI lineage. Activation of the FGF/ MAP kinase signal after the early blastocyst stage is necessary for generation of PE progenitors, and conversely, inhibition of the FGF/MAP kinase signal blocks PE formation [45, 54, 55] . Moreover, inhibition of FGF and GSK3 signaling in pre-EPI cells is essential for development of correctly specified EPI [56] .
The level of FGF signal in ICM directly or indirectly influences levels of Gata6 and Nanog expression, the classic PE and EPI specifiers, respectively. GATA6, a zinc finger transcription factor, most likely acting downstream of the FGF/ RAS/MAPK pathway, controls PE specification and is expressed exclusively in PE of the late blastocyst [45, 57] . NANOG, a homeodomain transcription factor, is essential for progression of ICM into EPI and is expressed exclusively in EPI in the late blastocyst [1, 23, 24] . Nanog null ICM do not mature into EPI [1, 24] , and interestingly, Nanog null mutants also fail to form PE, although some cells scattered in their ICM express PE markers [1] . Recently, Messerschmidt et al. [58] showed that NANOG, in addition to cell-autonomous promotion of EPI lineage, is also required to promote PE specification by a non-cell-autonomous mechanism, that is, signals from correctly specified EPI are necessary for PE formation. It has been proposed that there could be reciprocal regulation between PE-promoting GATA6 and EPI-promoting NANOG [45] . In such a model, NANOG directly represses Gata6 expression by binding to its promoter, and conversely, the GRB2-RTK pathway, which acts upstream of Gata6, represses Nanog expression in ES cells [45, 59] . However, most recent data have shown that Nanog expression is not required for inhibition of PE differentiation [58] . Further investigations are necessary to decipher the detailed molecular mechanism of interplay between FGF signaling and GATA6 and NANOG in PE/EPI lineage segregation.
Another transcription factor, SOX17, is important for PE specification. This factor was recently described as a PE marker [60] . ES cells that are Sox17 deficient do not differentiate into PE-like cells. SOX17 directly stimulates Gata6 and Gata4 expression, the PE specifiers, and inhibits pluripotency-related genes. It is proposed that SOX17 antagonizes NANOG action by competing for binding sites on the promoters of differentiation-promoting genes [61] .
Studies of mouse teratocarcinoma F9 cell lines, which are used as a model of PE differentiation, have revealed other factors that are necessary for differentiation of PE, such as retinoic acid (RA), SOX7, WNT6, and moesin [62] [63] [64] [65] . When cultured in RA-containing medium, F9 cells differentiate into PE [62] . RA acts upstream of SOX7, which in turn is required for the induction of GATA4 and GATA6 [63] . Expression of the Wnt6 gene, encoding a canonical WNT pathway transmitter, is upregulated in F9 cells in response to RA, and WNT6-expressing cells or cells exposed to WNT6-conditioned medium form PE [64] . Taken together, these data imply a role for RA signaling, SOX7, and the WNT signaling pathway in in vivo differentiation of PE.
GASPEROWICZ AND NATALE

Working Model of PE Versus EPI Lineage Segregation: Waves of Asymmetric Cell Divisions, Cell Sorting, Positional Induction, and a Pinch of Apoptosis
The finding that markers of PE and EPI are already expressed within ICM in the early blastocyst (E3.5) in an apparently random, mosaic, ''salt and pepper'' manner, combined with results of single-cell microarray analysis showing that individual cells from ICM of early blastocyst have distinct EPI-like or PE-like gene expression profiles, have led to the proposition of a ''salt and pepper'' predetermination model. According to this model, the ICM cells of the early blastocyst are already completely and exclusively predetermined to either of their future fates, and subsequently, in order to generate actual PE or EPI, the cells are sorted into their lineage-ascribed locations [45, 57, 66] . This model arose in opposition to the positional-induction model proposed earlier, which assumed that ICM cells are a fate-naïve, homogenous population and that the signals related to their localization within ICM induce those cells to become either EPI or PE [67] [68] [69] .
Interestingly, on the basis of very recent studies, a new model has emerged that integrates elements of the two previous models with known elements of asymmetric cell division. According to the newest model, early ICM cells are not completely predestined to their future fates and the EPI-versus-PE segregation depends on the origin of a given ICM cell and on simultaneous actions of two mechanisms: cell sorting and positional induction (Fig. 1B) [60, 70, 71] . Cell fate monitoring studies performed by Morris et al. [60] have demonstrated that whether a given ICM cell will become EPI or PE depends mostly, but not exclusively, on the wave of asymmetric cell division that generates that cell; so 75% of ICM cells generated by the first asymmetric cell division wave (8-to 16-cell stage) will become EPI, and 85% and 100% of ICM cells derived from the second (16-to 32-cell stage; ;E3.25) and third (32-to 64-cell stage; ;E3.5) asymmetric cell division waves, respectively, will give rise to PE. However, while the wave of origin predetermines cells in early mid blastocyst to become EPI or PE, it does not commit them to a given lineage; that is, cells still have the intrinsic ability to become either EPI or PE [55] . In the early blastocyst, expression of lineage determinants is nonmutually exclusive and nonregionally restricted, and cells demonstrate fate plasticity (Fig. 1B) [45, 46, 71, 72] . Singlecell expression profiling has shown that, in fact, all E3.5 ICM cells express high levels of both EPI and PE markers, Nanog and Gata 6 [73] . Gradually, the expression pattern becomes more mutually exclusive, reaching a generally nonoverlapping mosaic pattern of high Nanog-or high Gata 6-expressing cells at around mid blastocyst stage (E3.75) [45, 70, 71, 73] . During blastocyst maturation, cells predominantly expressing PE (pre-PE) markers migrate toward the edge of the ICM, while cells expressing EPI-related (pre-EPI) genes migrate toward the ICM center (Fig. 1B) . The migration is active, involving actins, and the combined actions of WNT9A and GATA6 are required for repositioning pre-PE cells [70, 71] . The mechanism of pre-PE migration includes changes in cell adhesion characteristics. Proteins involved in cell adhesion, collagen IV, DAB2, and LRP2, are expressed in pre-PE cells [74] . Additionally, mutants of the cell adhesion-related Dab2, Serpinb5, Lamc1, and Itgb1 (integrin b1) genes do not form the PE layer, but cells expressing PE markers are scattered within their ICM, suggesting that in those mutants, PE specification is initiated but cells fail to sort to the ICM surface [75] [76] [77] [78] [79] .
Occurring simultaneously with cell sorting and migration, positional induction mechanisms reinforce cell lineage commitment and probably induce as-yet noncommitted cells to express genes appropriate to the occupied position. Several lines of evidence support the role of positional signals in PE/ EPI segregation [70, 71] . First, isolated E3.5 ICMs form PE over their exterior surfaces [67, 68] , and the outer layer of embryoid bodies differentiates to form PE-derived tissue [69, 80] . Second, cell fate monitoring studies have demonstrated that in the early blastocyst, most cells occupy a position appropriate for their subsequent fate [60] . Third, live imaging data have revealed upregulation of a reporter construct representative of PE, an H2B-GFP fusion protein under the control of PDGFRA regulatory elements, in cells lining the blastocyst cavity, and downregulation of this construct in cells lying deeper [71] ; and, at last, computer modeling experiments have shown that the model of lineage segregation, which combines principles of both the cell sorting mechanism and the strong positional induction, provides the best fit to the data observed for in vivo cell tracking [70] .
A small number of cells in ICM, which likely represent mispositioned, pre-PE, and pre-EPI cells, undergo apoptosis [55, 60, 70, 71] . This selective apoptosis seems to be a cosmetic correction of PE-versus-EPI specification.
The ICM cells become fully committed to either EPI or PE lineage at around E3.75 [56] . At the late blastocyst stage, PE cells polarize and express compounds of basal lamina. By E4.5, the basal lamina, which separates PE from EPI, is formed, and the process of PE lineage specification is finished [74] .
BEYOND THE BLASTOCYST
What Is Beyond the PE? Parietal and Visceral Endoderm and Yolk Sac Formation
Following formation of the PE at the blastocyst stage, the next steps in development of this lineage are formation of the PaE, which lines the luminal surface of the mural TE, and the VE, which remains in contact with and surrounds the extraembryonic ectoderm and EPI (Fig. 2A) . The functions of VE and its derivative, the anterior VE, in anteroposterior patterning are beyond the scope of this review and are thoroughly and expertly reviewed elsewhere [81, 82] . Here we discuss mechanisms involved in PaE and VE differentiation in the context of yolk sac formation.
After implantation, PaE ultimately contributes to the parietal yolk sac, which acts as a protective layer to supports and facilitates transport of nutrients between the uterine tissue and the yolk sac cavity [83] . PaE consists of an outer layer of trophoblast giant cells in contact with cells of the uterus, a layer of PaE cells lining the embryonic surface of the implantation site, and a basement membrane (Reichert membrane) sandwiched between the two [3, 83] . Formation of the parietal yolk sac involves migration of PaE cells along the luminal surface of the TE. The F9 teratocarcinoma-derived embryoid body outgrowth system has been used to show migration is directed by the noncanonical Wnt planar cell polarity pathway via RHO/ROCK signaling [84, 85] . Reichert membrane is composed of collagen, laminin, entactin, and dystroglycan secreted by the PaE [86] [87] [88] . SOX7 is important in the process of parietal yolk sac formation; as in F9 cells, RA-stimulated Sox7 expression induces GATA4 and GATA6 activation, leading to differentiation of PaE from PE as well as production of laminin1 and collagen IV [63] . In an independent study of F9 cells, the PaE-specific expression of laminina1 was also shown to be under the control of SOX7 and SOX17 [89] . The formation of PaE and, consequently, the parietal yolk sac is essential for embryonic development, as highlighted by EARLY LINEAGE DETERMINATION IN THE MOUSE knockout of the dystroglycan gene, resulting in disruption of Reichert membrane and, subsequently, early embryonic lethality [88] .
Differentiation of PE to VE occurs in those cells of the PE that remain in contact with either the EPI or the ExE [3] . As stated previously, VE is important for mediating signals controlling differentiation and patterning of the EPI [5, 81] , and interestingly, VE has also recently been shown to contribute a small number of cells to the developing gut, a finding that suggests that segregation of extraembryonic and embryonic lineages within the embryo is not as strict as previously believed [90] . However, VE also contributes to the visceral and intraplacental yolk sacs (Fig. 2) . The visceral yolk sac functions to facilitate exchange of nutrients, oxygen, and waste products between the embryo and the maternal environment [91] and is formed at around E7.5, after the association of VE with an inner layer of extraembryonic mesoderm [3] . This mesodermal layer is derived from cells of the posterior primitive streak that undergo a series of complex morphogenetic movements. Mesoderm lines the inner surface of the VE and also contributes to formation of the proamnion and the chorion ( Fig. 2A) [3] . Following formation of the visceral yolk sac, blood islands begin to form within and are limited to its mesodermal layer. Blood island formation marks the beginning of the first events of embryonic hematopoiesis and vasculogenesis. The VE plays an inductive role in this process through several signaling pathways, such as RA, VEGF, and TGFB [91] [92] [93] . Later in pregnancy, after chorioallantoic attachment and concomitant with the onset of labyrinth development, the intraplacental yolk sac (IPYS) begins to form. The IPYS refers to epithelial cells that are an extension of the yolk sac cavity that expands into the chorio- 626 allantoic placenta at the border of the labyrinth layer and the allantoic mesoderm (Fig. 2, B-D) . This yolk sac cavity extension creates a space, referred to as the sinus of Duval [94, 95] . The sinus of Duval is lined by two types of epithelium, high columnar epithelium and squamous epithelium. The basement membranes of each epithelium type face the fetal blood vessels and maternal blood sinuses in the chorioallantoic disc, respectively. Columnar epithelium may be a derivative of the visceral yolk sac endoderm, while squamous epithelium likely derives from the PaE. These inferences were made based on morphology and the fact that both the visceral yolk sac endoderm and the columnar epithelium of the sinus of Duval express the vitamin D-dependent 9-kDa calcium binding protein (calbindin-D9k) [94, 95] . Furthermore, it has been shown that cells of the IPYS express PDGFRA and that PGDFRA is required for proper development of the IPYS [95] . Interestingly, while the function of the IPYS is not particularly well characterized, the expression of several calcitropic genes, including the PTHLH (PTHrP), PTHrP receptor, calcium receptor, calbindin-D9k, Ca 2þ -ATPase, and vitamin D receptor genes have lead to the hypothesis that IPYS may play a role in maternal-fetal calcium exchange [94, 96] .
From TE to ExE
Following implantation, the TE of the blastocyst gives rise to many different subtypes of trophoblast cells that facilitate interaction with the uterus and, ultimately, form the functional placenta. Cells of the mural TE (not in contact with the ICM) make contact with uterine epithelium and undergo terminal differentiation. The resulting trophoblast giant cells are postmitotic, migrate into the uterine tissue, and line the developing implantation site. The bulk of the developing placenta, however, is formed from the polar TE that overlays the ICM [97] [98] [99] [100] [101] . These cells proliferate to give rise to the ExE, which later forms the chorionic ectoderm and is the source of undifferentiated trophoblast stem cells, providing progenitors for the ectoplacental cone and, later, all of the different trophoblast subtypes required to form the mature placenta [100] [101] [102] .
Expression of the Eomes [11, 103] , Cdx2 [104, 105] , and Esrrb [106] [107] [108] transcription factors is required for the maintenance and proliferation of the ExE. This, in turn, is dependent in large part upon fibroblast growth factor 4 (FGF4), which is required not only for the proliferation of the ICM and development of the embryonic ectoderm following implantation [109] but is also essential for the derivation and maintenance of trophoblast stem cells in vitro [98, 110, 111] . As such, Fgf4 expression occurs in the ICM and following implantation in the developing EPI [112, 113] . Its receptor, Fgfr2, is expressed in a complementary pattern in the polar TE and ExE [114] . The mechanism by which FGF4 signals involves the extracellular regulated kinase (ERK) MAP kinase pathway. Several studies support this hypothesis. First, Mapk1 (Erk2) mutant mice die shortly after implantation due to a defect in ExE and ectoplacental formation [115, 116] . More recently, two groups have investigated the mechanism of FGF4 signaling and have shown in one study that FGF4 signals through the SRC/RAS/ERK pathway to inhibit the proapoptotic protein, BIM, thereby promoting trophoblast stem cell survival [117] . In a second study of TS cells in vitro, FGF4 was shown to activate the SRC/RAS/ERK pathway through FRS2, which resulted in the maintenance of Cdx2 expression [118] . FRS2 had previously been shown to be essential for maintenance of trophoblast stem cell self-renewal in response to FGF4 [111] .
In coordination with FGF4, members of the TGFB superfamily of growth factors, specifically TGFB, activin, and nodal, are necessary for regulation of trophoblast proliferation and differentiation within the ExE and in trophoblast stem cell cultures [93, [119] [120] [121] . In vitro studies have shown that TGFB or activin together with FGF4 are sufficient to support the proliferation and pluripotency of undifferentiated trophoblast stem cells in culture [119, 121] . In contrast, nodal is not [121] . However, while TGFB ligands and receptors are expressed in the uterine tissue as well as in the developing embryonic and extraembryonic tissues, mouse mutants have not revealed an essential role for this pathway in the trophoblast cell lineage [93, 122, 123] . Conversely, mutations in the type I activin receptor (Acvr1b) in mice result in early embryonic lethality, and mutants display a disorganized EPI and ExE at E6.5 [124] . Activin mutants have been made and have no obvious placental phenotypes [125] [126] [127] . However activin is encoded by three distinct subunit genes, and although single-and double-mutation mice have been reported, triple-mutation mice have not been reported. Nodal mutants display a phenotype similar to that of Acvr1b mutants; however, a hypomorphic mutation in nodal results in placental defects affecting trophoblast cells of the labyrinth, the spongiotrophoblast, and the trophoblast giant cell layers [128] . More insight has come from two studies in which NODAL, produced as an immature pro-protein by the EPI, was shown to act on the ExE to maintain expression of the subtilisin-like proprotein convertases FURIN and PACE4 [129] . In turn, FURIN and PACE4 cleaved the NODAL proprotein into its mature, active form, thereby providing a source of active Nodal that then acted on the EPI to maintain FGF4 expression as well as to specify anterior VE and mesoderm in the embryo [120, 129] . Taken together with findings from in vitro studies of trophoblast stem cells, these results imply that NODAL is unlikely to act directly on trophoblast stem cells to maintain proliferation and pluripotency but rather acts through the maintenance of FGF4 in the EPI. Instead, activin may be important in vivo for trophoblast stem cells. Interestingly, experiments with trophoblast stem cells in vitro suggest that activin and TGFB may also have an active role in controlling differentiation of trophoblast cells in the absence of FGF4 [121] . In that study [121] , activin, but not TGFB, was shown to significantly prolong Gcm1 expression, a marker of syncytiotrophoblast, while delaying the expression of markers of trophoblast giant cells. Conversely, TGFB appeared to preferentially promote the expression of markers of trophoblast giant cells [121] . Additional studies will be required to further investigate the relationships between these proteins as well as others in controlling trophoblast stem cell maintenance and differentiation.
CONCLUDING REMARKS
The blastocyst is a remarkable stage of development. First, it is the time when the first definitive differentiation events take place. Second, the implanted blastocyst is a starting point for development of extraembryonic and embryonic lineages that further interact and codevelop to ultimately generate an autonomous living organism.
In this review, we have highlighted a number of recent studies that provide novel and important insights that build upon our understanding of the regulation of lineage specification within the mouse blastocyst. It is clear that recent advances in the understanding of epigenetics and identification of novel roles of transcription factors and signaling pathways will provide new information relevant to these events. Furthermore, EARLY LINEAGE DETERMINATION IN THE MOUSE we have discussed mechanisms involved in the formation of extraembryonic tissues derived from three initial blastocyst lineages, specifically, the yolk sacs and the trophoblast-derived ExE. Uncovering more information about the mechanisms that control not only initial blastocyst lineage specification but also continued development of those lineages will lead to a clearer understanding of the interactions between the different tissues during development. Ultimately, this will provide greater insight into the control of cell proliferation and differentiation and hence a better understanding of both the development and the dynamics of stem cell populations that support it.
